A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia.

about

A phase 1/2 trial of lenalidomide and dexamethasone in adult patients with refractory/relapsed acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q40473999

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

A phase 1/2 trial of lenalidom ...... acute lymphoblastic leukemia.

@en

type

Item

label

A phase 1/2 trial of lenalidom ...... acute lymphoblastic leukemia.

@en

prefLabel

A phase 1/2 trial of lenalidom ...... acute lymphoblastic leukemia.

@en

P1476

A phase 1/2 trial of lenalidom ...... d acute lymphoblastic leukemia

@en

P2093

C Molucon-Chabrot

http://www.w3.org/2001/XMLSchema#string

D Guyotat

http://www.w3.org/2001/XMLSchema#string

E Tavernier-Tardy

http://www.w3.org/2001/XMLSchema#string

F Tinquaut

http://www.w3.org/2001/XMLSchema#string

J Cornillon

http://www.w3.org/2001/XMLSchema#string

J Y Cahn

http://www.w3.org/2001/XMLSchema#string

X Thomas

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor T cells for sustained remissions in leukemia

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Clinical efficacy of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase II study.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial.

Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.

Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation study.

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study.

Dose escalation of lenalidomide in relapsed or refractory acute leukemias.

Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma

P304

217-223

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/10245332.2016.1255372

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aurélie Bourmaud

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27848278

http://www.w3.org/2001/XMLSchema#string

P921

dexamethasone

phase I clinical trial

phase II clinical trial